---
figid: PMC4403665__nihms663395f1
figlink: /pmc/articles/PMC4403665/figure/F1/
number: F1
caption: TGF-β regulates normal and malignant MEC behavior by binding and activating
  two transmembrane Ser/Thr protein kinase receptors, namely TβR-I and TβR-II, whose
  binding to TGF-β is modulated by TβR-III. Activation of these ligand:receptor ternary
  complexes requires TβR-II to transphosphorylate TβR-I, which subsequently phosphorylates
  and activates Smad2/3. The phosphorylated forms of Smad2/3 form heterocomplexes
  with Smad4, which collectively accumulate in the nucleus to mediate canonical TGF-β
  signaling. Likewise, noncanonical TGF-β signaling transpires via the activation
  of an ever expanding list of downstream effectors, including integrins, FAK and
  Pyk2, MAP kinases, Src, PI3K/AKT/mTOR, NF-κB, and Cox-2. Also shown are various
  anti-TGF-β agents and their molecular targets. See text for additional details.
pmcid: PMC4403665
papertitle: Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway
  in Breast Cancers.
reftext: Yong-Hun Lee, et al. Breast Cancer Manag. 2014;3(1):73-85.
pmc_ranked_result_index: '96763'
pathway_score: 0.9397165
filename: nihms663395f1.jpg
figtitle: Chemotherapeutic Targeting of the Transforming Growth FactorB Pathway in
  Breast Cancers
year: '2014'
organisms:
- Mus musculus
- Rattus norvegicus
- Mouse mammary tumor virus
- Homo sapiens
ndex: 1ba41f96-df06-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4403665__nihms663395f1.html
  '@type': Dataset
  description: TGF-β regulates normal and malignant MEC behavior by binding and activating
    two transmembrane Ser/Thr protein kinase receptors, namely TβR-I and TβR-II, whose
    binding to TGF-β is modulated by TβR-III. Activation of these ligand:receptor
    ternary complexes requires TβR-II to transphosphorylate TβR-I, which subsequently
    phosphorylates and activates Smad2/3. The phosphorylated forms of Smad2/3 form
    heterocomplexes with Smad4, which collectively accumulate in the nucleus to mediate
    canonical TGF-β signaling. Likewise, noncanonical TGF-β signaling transpires via
    the activation of an ever expanding list of downstream effectors, including integrins,
    FAK and Pyk2, MAP kinases, Src, PI3K/AKT/mTOR, NF-κB, and Cox-2. Also shown are
    various anti-TGF-β agents and their molecular targets. See text for additional
    details.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R4
  - TGFB3
  - TGFBR2
  - PIK3CD
  - PIK3CG
  - PTK2
  - PIK3CB
  - AKT3
  - AKT1
  - TGFB2
  - PTK2B
  - NFKB1
  - TGFB1
  - MTOR
  - PIK3R3
  - SMAD2
  - PIK3CA
  - AKT2
  - SRC
  - PIK3R5
  - PIK3R6
  - SMAD3
  - SMAD4
  - SB-431542
  - SB-505124
  - LY364947
  - LY2109761
  - LY2157299
genes:
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TBR-II
  symbol: TBR-ii
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: FAK&Pyk2
  symbol: PYK2
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2B
  entrez: '2185'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: PI3K/AKT/MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Smad2
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/AKT/MTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/AKT/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Smad3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Smad4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
chemicals:
- word: SB-431542
  source: MESH
  identifier: C459179
- word: SB-505124
  source: MESH
  identifier: C519132
- word: LY364947
  source: MESH
  identifier: C520284
- word: LY2109761
  source: MESH
  identifier: C530108
- word: LY2157299
  source: MESH
  identifier: C557799
diseases: []
figid_alias: PMC4403665__F1
redirect_from: /figures/PMC4403665__F1
figtype: Figure
---
